Rhino-Orbitocerebral Mucormycosis Caused by Apophysomyces elegans
Open Access
- 1 March 2006
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (3) , 892-898
- https://doi.org/10.1128/jcm.44.3.892-898.2006
Abstract
Rhino-orbitocerebral mucormycosis (ROCM) caused by more common zygomycetes (e.g., Mucor ) is known to cause rapidly fatal infections in immunocompromised patients. Apophysomyces elegans is an emerging zygomycete that has been reported to cause invasive cutaneous and rhino-orbitocerebral infections in immunocompetent individuals. Limited data exist describing the syndrome of ROCM caused by A. elegans . We describe a recent case and performed a comprehensive literature review to delineate the clinical characteristics of ROCM caused by A. elegans . Our case is a 50-year-old man with diabetes mellitus who presented with facial pain and right eye proptosis. Endoscopic sinus sampling revealed A. elegans . He was treated with liposomal amphotericin B and multiple debridements, with no disease on 1.5-year follow-up examination. Seven cases were identified on literature review, including the present case. Most patients (86%) were male, with a mean age of 40 years. Most patients (71%) did not have predisposing medical conditions. Three patients had predisposing head trauma. All presented with facial and/or periorbital pain. All had magnetic resonance imaging or computed tomography of the head showing intraorbital and/or sinus inflammation. Diagnosis was confirmed by histopathology and deep tissue culture in all cases. All patients required eye exenteration and extensive surgical debridement, in addition to intravenous amphotericin B. Six of the seven patients (86%) recovered. ROCM caused by A. elegans is rarely reported in the literature. Most such infections occurred in immunocompetent patients, often after facial trauma. Survival in ROCM caused by A. elegans is favorable in reported cases, with prompt surgical debridement and antifungal therapy.Keywords
This publication has 29 references indexed in Scilit:
- Activity of posaconazole in the treatment of central nervous system fungal infectionsJournal of Antimicrobial Chemotherapy, 2005
- Mucormycosis (Zygomycosis) in a Heart-Kidney Transplant Recipient: Recovery after Posaconazole TherapyClinical Infectious Diseases, 2003
- Apophysomyces elegans : an Emerging Zygomycete in IndiaJournal of Clinical Microbiology, 2003
- Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of ZygomycosisAntimicrobial Agents and Chemotherapy, 2002
- Rhino-orbitocerebral Mucormycosis Attributable to Apophysomyces elegans in an Immunocompetent Individual: Case Report and Review of the LiteratureThe Journal of Trauma: Injury, Infection, and Critical Care, 2001
- Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patientOphthalmology, 2000
- Apophysomyces elegans infection in a renal transplant recipientAmerican Journal of Kidney Diseases, 1995
- Acute Invasive Rhinocerebral Zygomycosis in an Otherwise Healthy Patient: Case Report and ReviewClinical Infectious Diseases, 1995
- Successful Treatment of Extensive Posttraumatic Soft-Tissue and Renal Infections Due to Apophysomyces elegansClinical Infectious Diseases, 1994
- Invasive Infection Due to Apophysomyces elegans in Immunocompetent HostsClinical Infectious Diseases, 1993